Pure Global
NCT06308237

Effects of Resisted Versus Balance Exercises on Cognitive And Motor Function In Patients With Mild Cognitive Impairment

Riphah International University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Drug/Device/Intervention
RESISTED EXERCISES
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Riphah International University
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Feb 25, 2024
End date
Jun 25, 2024
Enrollment
66 participants
Primary outcome

MoCA (Montreal Cognitive Assessment ),Mini-Balance Evaluation Systems Test (BESTest).,Timed UP and GO Test (TUG) :,Computerized battery test (CBT)

Summary

Mild cognitive impairment affects older adults and it includes memory and attentions
 deficits, and problem-solving difficulties in activities of daily living. Resisted exercises
 is considered a viable strategy to improve balance and motor function in older population.
 Balance exercises comprises proprioceptive, visual and motor learning to a larger degree and
 has positive effects on memory and spatial cognition and improves balance and motor function.
 This study aims to determine the effects of resisted and balance exercises on cognition and
 motor function in patients with mild cognitive impairment.

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06308237
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06308237 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 66 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.